DONATE GIVING DAY Eli Ipp, MD, is Lead Author on a JAMA Open Network Study that Positively Evalua… NOVEMBER 19, 2021 The study examines performance of the EyeArt AI system for detecting eyes with more than mild diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopathy (vtDR). Lundquist Institute Investigators Develop a Significant Novel Mouse Model of th… NOVEMBER 19, 2021 Ataxia Telangiectasia (A-T) Is a Devastating Disorder in Children Characterized by a Severe Loss of Motor Coordination (Ataxia), Increased Cancer Susceptibility, Immunodeficiency, and Premature Death The Lundquist Institute Receives $3 Million From NIH to Expand Male Contracepti… NOVEMBER 2, 2021 The Lundquist Institute’s Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes of Health (NIH) to expand its work and recruit 120+ more couples. Fall 2021 THE INSTITUTE'S RAPID RESPONSE TO THE THE PANDEMIC VACCINE ROUNDTABLE Lundquist Legend: Dr. K.R. Tanaka | Meet Our Scientist: Lynda Polgreen, MD | Repairing A Damaged Brain Prestigious $5 Million CIRM Scholar Research Training Award Received SEPTEMBER 24, 2021 Received a generous $5 million, 5-year grant from the California Institute for Regenerative Medicine (CIRM) that will allow its PhD students, postdoctoral fellows and clinical fellows to pursue careers in … Early Use of Convalescent Plasma for COVID-19 Disease Progression USE DOES NOT PREVENT COVID-19 DISEASE PROGRESSION Investigators at The Lundquist Institute and research colleagues at other institutions have found that passive immunization is not a viable strategy . BioLabs LA at The Lundquist Institute Reaches 100% Capacity THE INSTITUTE'S INCUBATOR NOW HOUSES 30 START-UPS This critical milestone demonstrates the strong demand for entrepreneurial startup opportunities in the bioscience sphere in Los Angeles. The Impact of COVID-19 on Children, Adolescents, and Family Wellness WEDNESDAY, JUNE 30, 2021 AT 5:30 PM PACIFIC A Lundquist Institute Community Science Series Virtual Webinar Lundquist Investigators Contribute to Global Genomic Research Study STUDY EXPANDS GENOMIC RESEARCH INTO DIVERSE, DIFFERENT ANCESTRIES Studies included data on Hispanics, African-Americans and East Asians. Mystery Solved LONGSTANDING FALLOPIAN TUBE TRANSPORT DEBATE A group of investigators led by The Lundquist Institute's Wei Yan, MD, PhD demonstrated that motile cilia in the Fallopian tube are essential for oocyte pickup. Spearheading Life-Saving COVID-19 Research RESEARCH SUPPORTS CORE MISSION TO SAVE LIVES AND EMPOWER HEALTHCARE EQUITY The Lundquist Institute has led or participated in eight COVID-19 clinical studies whose results have changed the world. New Promising Compound for Male Contraceptive Pill NON-HORMONAL COMPOUND PURIFIED FROM CHINESE HERB Institute researchers discovered a natural compound that exhibits almost ideal male contraceptive effects in pre-clinical studies. Quick Links Clinical Trials Innovation Licensing Internship Inquiry Contact Us Visit Our Campus Contribute Become a Friend Planned Giving Donate Now Employee Links Benefits Remote Access Working at The Lundquist Institute Careers DONATE TODAY Search Social Links